Clinical Trials

SGS will provide its services to support the development of AstraZeneca’s Covid-19 vaccine candidate – AZD1222 – which was co-invented by the University of Oxford and its spin-out company Vaccitech. The vaccine is currently undergoing human trials in a...

Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms of COVID-19 – a critical need in the absence of a vaccine or curative treatment. Inflammation...

Biogen Inc announced it plans to initiate a global Phase 4 clinical study, RESPOND, to examine the clinical benefit and assess the safety of SPINRAZA® (nusinersen) in infants and children with spinal muscular atrophy (SMA) who still have unmet...

An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday. The vaccine, called AZD1222 and being developed by pharmaceutical company AstraZeneca...

Moderna, an American biotech company announced on July 14 that its COVID-19 vaccine candidate is finally going to enter the final phase on July 27 as it has shown positive results in previous human trials. Undoubtedly, this is a...

The Alzheimer's Clinical Trials Consortium , Eisai Co., Ltd and Biogen Inc announced that a new phase III clinical study (AHEAD 3-45) of BAN2401, an anti-amyloid beta (Aß) protofibril antibody, has been initiated in the United States of America...

Orgenesis Inc., a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs), announces that it has entered into a Collaboration Agreement with Educell Ltd., a premier European cell therapy company....